Skip to content
Tallac Therapeutics, Inc
Tallac Therapeutics, Inc

News

Home
News
2023
  • 3 Nov, 2023

Tallac Presents First Clinical Data for TAC-001 at SITC 2023

  • 27 Sep, 2023

Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

view more
Tallac Therapeutics, Inc
  • (650) 866-1966
866 Malcolm Road Suite 100, Burlingame, CA 94010
Linkedin-in Envelope

Copyright © 2020-2025 Tallac Therapeutics, Inc. All Rights Reserved.